Biography and Research Information
OverviewAI-generated summary
Amairani Paredes' research focuses on infectious diseases and their impact on health, particularly in pediatric populations. Her work has investigated the seroprevalence of SARS-CoV-2 in children in Arkansas during the initial year of the COVID-19 pandemic. Additionally, her research has explored the role of specific viral genes in the development of myocarditis, specifically examining the M2 gene's contribution to reovirus-induced myocarditis in animal models. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including J. Craig Forrest, Catherine Kirkpatrick, Shana M. Owens, and Joshua L. Kennedy, on shared publications. Paredes has published four papers, accumulating 42 citations, and holds an h-index of 3.
Metrics
- h-index: 3
- Publications: 4
- Citations: 42
Selected Publications
-
Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic (2022)
-
The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis (2021)
-
Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic (2021)
-
The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis (2021)
Collaboration Network
Top Collaborators
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Similar Researchers
Based on overlapping research topics